Third Arc Bio

Developer of therapetics for cancer and immunological diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2022 language thirdarcbio.com

Social engagement

Social engagement: 3.7K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Vida Ventures, Cormorant Asset Management, Hillhouse, Andreessen Horowitz.

Investor typeCountShare
Venture capital646%
Private equity215%
Bank & private debt18%
Other / undisclosed431%

Recent activity

13 Nov 2025
Partnership
Adagene
19 Sep 2025
Recognition
Coming soon